Hunan Fangsheng Pharm Co Ltd
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infe… Read more
Hunan Fangsheng Pharm Co Ltd (603998) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.055x
Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million) by net assets (CN¥1.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hunan Fangsheng Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STCube Inc
KQ:052020
|
-0.064x |
|
SOUTH PLAINS FINAN. DL 1
F:4S4
|
N/A |
|
Sgis Songshan Co Ltd
SHE:000717
|
0.079x |
|
34Q0
F:34Q0
|
-0.039x |
|
IntelliEPI Cayman
TWO:4971
|
0.027x |
|
LANXESS Aktiengesellschaft
PINK:LNXSY
|
0.013x |
|
Merida Industry Co Ltd
TW:9914
|
0.057x |
|
LAMDA DEVELOPM. NA EO-30
F:LDQ
|
N/A |
Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.73 Billion | CN¥194.95 Million | 0.112x | +103.94% |
| 2023-12-31 | CN¥1.59 Billion | CN¥87.54 Million | 0.055x | -72.45% |
| 2022-12-31 | CN¥1.51 Billion | CN¥301.63 Million | 0.200x | +40.48% |
| 2021-12-31 | CN¥1.30 Billion | CN¥185.63 Million | 0.142x | -23.85% |
| 2020-12-31 | CN¥1.27 Billion | CN¥236.66 Million | 0.187x | +38.29% |
| 2019-12-31 | CN¥1.20 Billion | CN¥162.58 Million | 0.135x | -14.54% |
| 2018-12-31 | CN¥1.11 Billion | CN¥176.06 Million | 0.158x | +925.77% |
| 2017-12-31 | CN¥1.04 Billion | CN¥16.00 Million | 0.015x | -87.27% |
| 2016-12-31 | CN¥979.69 Million | CN¥118.70 Million | 0.121x | +24.64% |
| 2015-12-31 | CN¥931.73 Million | CN¥90.57 Million | 0.097x | -13.08% |
| 2014-12-31 | CN¥841.94 Million | CN¥94.16 Million | 0.112x | -64.82% |
| 2013-12-31 | CN¥386.85 Million | CN¥122.97 Million | 0.318x | +318.63% |
| 2012-12-31 | CN¥318.83 Million | CN¥24.21 Million | 0.076x | -69.88% |
| 2011-12-31 | CN¥258.49 Million | CN¥65.16 Million | 0.252x | -- |